Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

168 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Skin-depigmenting agent monobenzone induces potent T-cell autoimmunity toward pigmented cells by tyrosinase haptenation and melanosome autophagy.
van den Boorn JG, Picavet DI, van Swieten PF, van Veen HA, Konijnenberg D, van Veelen PA, van Capel T, Jong EC, Reits EA, Drijfhout JW, Bos JD, Melief CJ, Luiten RM. van den Boorn JG, et al. Among authors: jong ec. J Invest Dermatol. 2011 Jun;131(6):1240-51. doi: 10.1038/jid.2011.16. Epub 2011 Feb 17. J Invest Dermatol. 2011. PMID: 21326294 Free article.
Fc gamma receptor IIa suppresses type I and III interferon production by human myeloid immune cells.
Newling M, Hoepel W, Vogelpoel LTC, Heineke MH, van Burgsteden JA, Taanman-Kueter EWM, Eggink D, Kuijpers TW, Beaumont T, van Egmond M, Kapsenberg ML, Baeten DLP, den Dunnen J, Jong EC. Newling M, et al. Among authors: jong ec. Eur J Immunol. 2018 Nov;48(11):1796-1809. doi: 10.1002/eji.201847615. Epub 2018 Sep 14. Eur J Immunol. 2018. PMID: 30184252 Free PMC article.
Plant-produced Der p 2-bearing bioparticles activate Th1/Treg-related activation patterns in dendritic cells irrespective of the allergic background.
Busold S, Aglas L, Menage C, Desgagnés R, Faye L, Fitchette AC, de Jong EC, Martel C, Stigler M, Catala-Stordeur V, Tropper G, Auger L, Morel B, Versteeg SA, Vézina LP, Gomord V, Layhadi JA, Shamji M, Geijtenbeek TBH, van Ree R. Busold S, et al. Among authors: de jong ec. Clin Exp Allergy. 2024 Apr;54(4):300-303. doi: 10.1111/cea.14456. Epub 2024 Jan 27. Clin Exp Allergy. 2024. PMID: 38279775 No abstract available.
Sialic acid-modified der p 2 allergen exerts immunomodulatory effects on human PBMCs.
Keumatio Doungtsop BC, Nardini E, Kalay H, Versteeg SA, Lübbers J, van Barneveld G, Li ERJ, van Vliet SJ, van Ree R, de Jong EC, van Kooyk Y. Keumatio Doungtsop BC, et al. Among authors: de jong ec. J Allergy Clin Immunol Glob. 2023 Nov 20;3(1):100193. doi: 10.1016/j.jacig.2023.100193. eCollection 2024 Feb. J Allergy Clin Immunol Glob. 2023. PMID: 38187864 Free PMC article.
A novel peanut allergy immunotherapy: Plant-based enveloped Ara h 2 Bioparticles activate dendritic cells and polarize T cell responses to Th1.
Castenmiller C, Nagy NA, Kroon PZ, Auger L, Desgagnés R, Martel C, Mirande L, Morel B, Roberge J, Stordeur V, Tropper G, Vézina LP, van Ree R, Gomord V, de Jong EC. Castenmiller C, et al. Among authors: de jong ec. World Allergy Organ J. 2023 Nov 10;16(11):100839. doi: 10.1016/j.waojou.2023.100839. eCollection 2023 Nov. World Allergy Organ J. 2023. PMID: 38020282 Free PMC article.
Aberrant neutrophil degranulation in hospitalized patients with COVID-19 partially remains for 6 months.
Hafkamp FMJ, Taanman-Kueter EWM, van Capel TMM, Wynberg E, van Willigen HDG, Verveen A, Kootstra NA, Nieuwkerk P, de Jong MD, de Bree GJ, Prins M; RECoVERED study group; Hazenberg MD, Groot Kormelink T, de Jong EC. Hafkamp FMJ, et al. Among authors: de jong ec. Eur J Immunol. 2024 Jan;54(1):e2350404. doi: 10.1002/eji.202350404. Epub 2023 Oct 30. Eur J Immunol. 2024. PMID: 37853954
Correction: Inflammatory and tolerogenic myeloid cells determine outcome following human allergen challenge.
Voskamp AL, Tak T, Gerdes ML, Menafra R, Duijster E, Jochems SP, Kielbasa SM, Kormelink TG, Stam KA, van Hengel ORJ, de Jong NW, Hendriks RW, Kloet SL, Yazdanbakhsh M, de Jong EC, Gerth van Wijk R, Smits HH. Voskamp AL, et al. Among authors: de jong ec. J Exp Med. 2023 Sep 4;220(9):e2022111108162023c. doi: 10.1084/jem.2022111108162023c. Epub 2023 Aug 18. J Exp Med. 2023. PMID: 37594459 Free PMC article. No abstract available.
Inflammatory and tolerogenic myeloid cells determine outcome following human allergen challenge.
Voskamp AL, Tak T, Gerdes ML, Menafra R, Duijster E, Jochems SP, Kielbasa SM, Kormelink TG, Stam KA, van Hengel ORJ, de Jong NW, Hendriks RW, Kloet SL, Yazdanbakhsh M, de Jong EC, Gerth van Wijk R, Smits HH. Voskamp AL, et al. Among authors: de jong ec. J Exp Med. 2023 Sep 4;220(9):e20221111. doi: 10.1084/jem.20221111. Epub 2023 Jul 10. J Exp Med. 2023. PMID: 37428185 Free PMC article.
168 results